ID: ALA4785500

Max Phase: Preclinical

Molecular Formula: C20H24BrNO

Molecular Weight: 294.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  OC1C[N+]2(Cc3ccc(-c4ccccc4)cc3)CCC1CC2.[Br-]

Standard InChI:  InChI=1S/C20H24NO.BrH/c22-20-15-21(12-10-19(20)11-13-21)14-16-6-8-18(9-7-16)17-4-2-1-3-5-17;/h1-9,19-20,22H,10-15H2;1H/q+1;/p-1

Standard InChI Key:  PGWGKOMTIJQBPF-UHFFFAOYSA-M

Associated Targets(Human)

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HT-29 80576 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

RS4-11 1012 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CCRF-CEM 65223 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Choline kinase alpha 330 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 294.42Molecular Weight (Monoisotopic): 294.1852AlogP: 3.45#Rotatable Bonds: 3
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.20CX Basic pKa: CX LogP: -0.93CX LogD: -0.93
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.86Np Likeness Score: 0.39

References

1. Serrán-Aguilera L,Mariotto E,Rubbini G,Castro Navas FF,Marco C,Carrasco-Jiménez MP,Ballarotto M,Macchiarulo A,Hurtado-Guerrero R,Viola G,Lopez-Cara LC.  (2020)  Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism.,  207  [PMID:32977218] [10.1016/j.ejmech.2020.112797]

Source